Back to search
Neovascular Age-Related Macular Degeneration (NVAMD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neovascular Age-Related Macular Degeneration (NVAMD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neovascular Age-Related Macular Degeneration (NVAMD) trials you may qualify forResearchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as af…
Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as af…
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema…
EYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will recei…
EYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy or neovascul…